TE-15Homo sapiens (Human)Cancer cell line

Also known as: Te15, TE15

🤖 AI SummaryBased on 8 publications

Quick Overview

Human esophageal squamous cell carcinoma cell line

Detailed Summary

TE-15 is a human esophageal squamous cell carcinoma cell line derived from the TE series. It is used in research to study the molecular mechanisms of esophageal cancer, including genetic alterations, gene expression, and drug sensitivity. The cell line has been utilized in studies examining the role of LRP1B in cancer progression and the effects of epigenetic modifications on gene expression. TE-15 is also part of large-scale genomic and pharmacological studies to identify potential therapeutic targets and biomarkers for cancer treatment.

Research Applications

Molecular mechanisms of esophageal cancerGenetic alterations in cancerGene expression studiesDrug sensitivity profilingEpigenetic modifications in cancer

Key Characteristics

Derived from esophageal squamous cell carcinomaUsed in studies of LRP1B and cancer progressionPart of large-scale genomic and pharmacological studies
Generated on 6/17/2025

Basic Information

Database IDCVCL_1763
SpeciesHomo sapiens (Human)
Tissue SourceEsophagus[UBERON:UBERON_0001043]

Donor Information

Age58
Age CategoryAdult
SexFemale

Disease Information

DiseaseSquamous cell carcinoma of the esophagus
LineageEsophagus/Stomach
SubtypeEsophageal Squamous Cell Carcinoma
OncoTree CodeESCC

DepMap Information

Source TypeRIKEN
Source IDACH-000353_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53c.560-1G>AUnspecifiedSplice acceptor mutationPubMed=9096669

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D13S317
12
D16S539
9
D5S818
9
D7S820
11
TH01
7
TPOX
9
vWA
15,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

Nature 568:511-516(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.

Lowe A.W., Beverloo H.B., van Dekken H., Tilanus H.W., Dinjens W.N.M.

Cancer Res. 67:7996-8001(2007).

Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.

Imamura M., Amagasa T., Gray J.W., Hirohashi S., Inazawa J.

Cancer Res. 64:3741-3747(2004).

Screening the p53 status of human cell lines using a yeast functional assay.

Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.

Mol. Carcinog. 19:243-253(1997).

Inactivation of the p53 protein in cell lines derived from human esophageal cancers.

Hainaut P.

Int. J. Cancer 71:79-87(1997).

Molecular and cellular features of esophageal cancer cells.";

Nishihira T., Hashimoto Y., Katayama M., Mori S., Kuroki T.

J. Cancer Res. Clin. Oncol. 119:441-449(1993).